RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Newron Pharmaceuticals S p a
Newron Pharmaceuticals S p a_20100121
  

Newron Pharmaceuticals S p a patents

Recent patent applications related to Newron Pharmaceuticals S p a. Newron Pharmaceuticals S p a is listed as an Agent/Assignee. Note: Newron Pharmaceuticals S p a may have other listings under different names/spellings. We're not affiliated with Newron Pharmaceuticals S p a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Newron Pharmaceuticals S p a-related inventors




Date Newron Pharmaceuticals S p a patents (updated weekly) - BOOKMARK this page
02/02/17Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
11/17/16Fluorinated arylalkylaminocarboxamide derivatives
06/11/15Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
06/11/15Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
06/11/15Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
06/11/15Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
06/11/15Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
06/04/15Methods for treatment of parkinson's disease
03/27/14Fluorinated arylalkylaminocarboxamide derivatives
02/20/14High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
02/28/13Methods for treatment of parkinson's disease
02/14/13Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
08/30/122-phenylethylamino derivatives as calcium and/or sodium channel modulators
06/21/12Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
06/07/12Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
07/28/11Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
02/24/112-phenylethylamino derivatives as calcium and/or sodium channel modulators
01/20/11Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
12/23/10High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof
08/19/10Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
02/25/103-aminopyrrolidone derivatives
01/21/10Alpha-aminoamide derivatives useful as anti-inflammatory agents
06/18/09Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
01/21/10Alpha-aminoamide derivatives useful as anti-inflammatory agents







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Newron Pharmaceuticals S p a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Newron Pharmaceuticals S p a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';